Cytokine therapy for craniosynostosis

Bibliography

• ENLOW DH: Handbook of Facial Growth. Saunders, Philadelphia (1990).
   Google Scholar
• COHEN MM JR: Sutural biology and the correlates of craniosynostosis. Am. J. Med. Genet. (1993) 47:581–616.
   PubMed Web of Science ®Google Scholar
• COHEN MM JR: Sutural biology. In: Craniosynostosis: Diagnosis, Evaluation, and Management. Cohen MM Jr, MacLean RE (Eds), Oxford University Press, New York (2000):11–23.
   Google Scholar
• ••Excellent review of sutures anatomy and biology.
   Google Scholar
• BABLER W: Relationship of altered cranial suture growth to cranial base and midface. In: Scientific Foundations and Surgical Treatment of Craniosynostosis. Persing JA, Edgerton MT, Jane JA (Eds), Williams and Wilkins, Baltimore (1989):87–95.
   Google Scholar
• MOONEY MP, LOSKEN HW, SIEGEL MI et al.: Development of a strain of rabbits with congenital simple, nonsyndromic coronal suture synostosis. Part 2. Somatic and craniofacial growth patterns. Cleft Palate Craniofac. J. (1994) 31:8–14.
   Google Scholar
• KREIBORG S: Postnatal growth and development of the craniofacial complex in premature craniosynostosis. In: Craniosynostosis: Diagnosis, Evaluation, and Management. Cohen MM Jr, MacLean RE (Eds), Oxford University Press, New York (2000):158–176.
   Google Scholar
• RICHTSMEIER JT: Cranial vault dysmorphology and growth in craniosynostosis. In: Understanding Craniofacial Anomalies: The Etiopathogenesis of Craniosynostoses and Facial Clefring. Mooney MP, Siegel MI (Eds), John W. Wiley and Sons, New York (2002):321–342.
   Google Scholar
• RENIER D: Intracranial pressure in craniosynostosis: pre- and postoperative recordings-correlation with functional results. In: Scientific Foundations and Surgical Treatment of Craniosynostosis. Persing JA, Edgerton MT, Jane JA (Eds), Williams and Wilkins, Baltimore (1989):263–269.
   Google Scholar
• CAMPBELL JW, ALBRIGHT AL, LOSKEN HW et al.: Intracranial hypertension after cranial vault decompression for craniosynostosis. Pediatr. Neurosurg. (1995) 22:270–273.
   PubMed Web of Science ®Google Scholar
• MOONEY MP, SIEGEL MI, BURROWS AM et al.: A rabbit model of human familial, nonsyndromic, unicoronal suture synostosis: Part 2: Intracranial contents, intracranial volume, and intracranial pressure. Childs Nerv. Sys. (19986) 14:247–255.
   Google Scholar
• MOONEY MP, FELLOWS-MAYLE W, DECHANT J et al.: Increases in intracranial pressure following coronal suturectomy in rabbits with craniosynostosis. Craniofac. Sing. (1999) 10:104–111.
   PubMed Web of Science ®Google Scholar
• CAMFIELD PR, CAMFIELD CS, COHEN MM JR: Neurological aspects of craniosynostosis. In: Craniosynostosis: Diagnosis, Evaluation, and Management. Cohen MM Jr, MacLean RE (Eds), Oxford University Press, New York (2000):177–183.
   Google Scholar
• FELLOWS-MAYLE W, MOONEY MP, DECHANT J et al.: Longitudinal intracranial pressure changes in craniosynostotic rabbits. Cleft Palate Craniofac. J. (2000) 37:370–378.
   PubMed Web of Science ®Google Scholar
• GAULT DT, RENIER D, MARCHAC D et al: Intracranial pressure and intracranial volume in children with craniosynostosis. Plast. Reconstr. Surg. (1992) 90:377–381.
   PubMed Web of Science ®Google Scholar
• POLLACK IF, LOSKEN HW, BIGLAN A: Incidence of increased intracranial pressure after early surgical treatment of syndromic craniosynostosis. Pediatr. Neurosurg. (1996) 24:202–205.
   PubMed Web of Science ®Google Scholar
• HUD GINS RJ, COHEN SR, BURSTEIN FD et al.: Multiple suture synostosis and increased intracranial pressure following repair of single suture, nonsyndromic craniosynostosis. Cleft Palate Craniofac. J. (1998) 35:167–172.
   PubMed Web of Science ®Google Scholar
• SINGHAL VK, MOONEY MP, BURROWS AM et al.: Related changes in intracranial volume in craniosynostotic rabbits using 3-D CT scans. Plast. Reconstr. Surg. (1997) 100:1121–1128.
   PubMed Web of Science ®Google Scholar
• MOONEY MP, BURROWS AM, WIGGINTON W et al.: Intracranial volume in craniosynostotic rabbits. Craniofac. Surg. (1998) 9:234–239.
   PubMed Web of Science ®Google Scholar
• CHADDUCK WM, CHADDUCK JB, BOOP FA: The subarachnoid spaces in craniosynostosis. Neurosurg. (1992) 30:867–871.
   PubMed Web of Science ®Google Scholar
• MILLER MT: Ocular findings in craniosynostosis. In: Craniosynostosis: Diagnosis Evaluation, and Management. Cohen MM Jr, MacLean RE (Eds), Oxford University Press, New York (2000):184–196.
   Google Scholar
• KAPP-SIMMONDS KA, FIGUEROA A, JOCHER CA et al.: Longitudinal assessment of mental development in infants with nonsyndromic craniosynostosis with and without cranial release and reconstruction. Plast. Reconstr. Surg. (1993) 92:831–841.
   PubMed Web of Science ®Google Scholar
• ARNAUD E, RENTER D, MARCHAC D: Prognosis for mental function in scaphocephaly. Neurosurg. (1995) 83:476–479.
   Web of Science ®Google Scholar
• PERSING JA, JANE J:. Neurosurgical treatment of craniosynostosis. In: Craniosynostosis: Diagnosis, Evaluation, and Management. Cohen MM Jr, MacLean RE (Eds), Oxford University Press, New York (2000):209–227.
   Google Scholar
• MITCHELL R, BARBANO TE, LOSKEN HW et al.: Early neuromotor behavior in craniosynostotic rabbits. Cleft Palate Craniofac. (2003) 40:486–492.
   PubMed Web of Science ®Google Scholar
• MARCHAC D, RENTER D: Craniofacial Surgery For Craniosynostosis Little Brown & Co., Boston (1982).
   Google Scholar
• MARSH JL, VANNIER MW: Comprehensive Care for Craniofacial Deformities. C.V. Mosby, Co., St. Louis, MO, USA (1985).
   Google Scholar
• TURVEY TA, VIG KWL, FONSECA RL: Facial Clefts and Craniosynostosis: Principles and Management. W.B. Saunders, Philadelphia (1996).
   Google Scholar
• POSNICK JC: Craniofacial and Maxillofacial Surgery M Children and Young Adults: Volume I and Volume 2 W.B. Saunders, Philadelphia (2000).
   Google Scholar
• POSNICK JC: Craniosynostosis and the craniofacial dysostosis syndromes: current surgical management. In: Craniosynostosis: Diagnosis, Evaluation, and Management. Cohen MM Jr, MacLean RE (Eds), Oxford University Press, New York (2000):269–291.
   Google Scholar
• TESSIER P: Craniofacial surgery in syndromic craniosynostosis. In: Craniosynostosis: Diagnosis Evaluation, and Management. Cohen MM Jr, MacLean RE (Eds), Oxford University Press, New York (2000):228–269.
   Google Scholar
• PANCHAL J, UTTCHIN V: Management of Craniosynostosis. Plast. Reconstr. Surg. (2003) 111:2032–2048.
   PubMed Web of Science ®Google Scholar
• •Good review of recent clinical and surgical management protocols of craniosynostosis.
   Google Scholar
• PERSING JA, JANE JA, EDGERTON MA: Surgical treatment of craniosynostosis. In: Scientific Foundations and Surgical Treatment of Craniosynostosis. Persing JA, Edgerton MT, Jane JA (Eds), Williams and Wilkins, Baltimore (1989):87–95.
   Google Scholar
• MCCARTHY JG, GLASBERG SB, CUTTING CB et al.: Twenty years experience with early surgery for craniosynostosis. I. Isolated craniofacial synostosis: results and unsolved problems. Plast. Reconstr. Surg. (1995) 96:284–302.
   Google Scholar
• WARREN S, LONGAKER MT: The pathogenesis of craniosynostosis in the fetus. Yonsei Med. J. (2001) 42:646–659.
   PubMed Web of Science ®Google Scholar
• •Good review of suture biology and future clinical applications related to craniosynostosis.
   Google Scholar
• NORWOOD CW, ALEXANDER E, DAVIS CH et al.: Recurrent and multiple suture closures after craniectomy for craniosynostoses. Neurosurg. (1974) 41:715–719.
   Web of Science ®Google Scholar
• HASSLER W, ZENTNER J: Radical osteoclastic, craniectomy in sagittal synostosis. Neurosurg. (1990) 27:539–546.
   PubMed Web of Science ®Google Scholar
• FATAH MFT, ERMIS I, POOLE MD et al.: Prevention of cranial reossicification after surgical craniectomy. Craniofac. Surg. (1992) 3:170–172.
   PubMedGoogle Scholar
• DRAKE D, PERSING JA, BERMAN DE et al.: Calvarial deformity regeneration following subtotal calvariectomy for craniosynostosis: a case report and theoretical implications. I Craniofac. Surg. (1993) 4:85–89.
   PubMedGoogle Scholar
• KIRKPATRICK WNA, KOSHY CE, WATERHOUSE N et al.: Peadiatric transcranial surgery: a review of 114 consecutive cases. Br. Plast. Surg. (2002) 55:561–564.
   PubMed Web of Science ®Google Scholar
• MOMMAERTS MY, STAELS PF, CASSELMAN JW: The faith of a coronal suture grafted onto midline synostosis inducing dura and deprived from tensile stress. Cleft Palate Craniofac. (2001) 38:533–537.
   PubMed Web of Science ®Google Scholar
• GREENE CS JR: Pancraniosynostosis after surgery for single sutural craniosynostosis. Pediatr. Neurosurg. (1998) 29:127–132.
   PubMed Web of Science ®Google Scholar
• MOONEY MP, BURROWS AM, LOSKEN HW et al.: Correction of coronal suture synostosis using suture and dura mater allografts in rabbits with familial craniosynostosis. Cleft Palate Craniofac. (2001) 38:206–225.
   PubMed Web of Science ®Google Scholar
• JANE JA, PERSING JA: Neurosurgical treatment of craniosynostosis. In: Craniosynostosis: Diagnosis Evaluation, and Management. Cohen MM (Ed.), Raven Press, New York (1986):249–320.
   Google Scholar
• MOREIRA-GONZALEZ A, JACKSON IT, MIYAWAKI T et al: Clinical outcomes in cranioplasty: critical review in long-term followup. Craniofac. Surg. (2003) 14:144–153.
   PubMed Web of Science ®Google Scholar
• WILLIAMS JK, COHEN SR, BURSTEIN FD et al.: A longitudinal, statistical study of reoperation rates in craniosynostosis. Plast. Reconstr. Surg. (1997) 100:305–310.
   PubMed Web of Science ®Google Scholar
• OPPERMAN LA, OGLE RC: Molecular studies of craniosynostosis: factors affecting cranial suture morphogenesis and patency. In: Understanding Craniofacial Anomalies: The Etiopathogenesis of Craniosynostoses and Facial Clefting. Mooney MP, Siegel MI (Eds), John W. Wiley and Sons, New York (2002):497–518.
   Google Scholar
• ••Excellent review of recent findings insuture biology.
   Google Scholar
• OGLE RC, THOLPADY SS, MCGLYNN KA et al.: Regulation of cranial suture morphogenesis. Cells Tiss. Org. (2004) an Press).
   Google Scholar
• BOYAN BD, LOHMANN CH, ROMERO J, SCHWARTZ Z: Bone and cartilage tissue engineering. Clin. Plast. Surg. (1999) 26:629–645.
   PubMed Web of Science ®Google Scholar
• ALSBERG E, ANDERSON KW, ALBEIRUTI A, ROWLEY JA, MOONEY DJ: Engineering growing tissues. Proc. Nati Acad. Sci. USA (2002) 99:12025–12030.
   PubMed Web of Science ®Google Scholar
• ALSBERG E, HILL EE, MOONEY DJ: Craniofacial tissue engineering. Grit. Rev Oral Biol. Med. (2001) 12:64–75.
   PubMedGoogle Scholar
• WILKIE AOM, WALL SA: Craniosynostosis: novel insights into pathogenesis and treatment. Curt Opin. Neurol (1996) 9:146–152.
   PubMed Web of Science ®Google Scholar
• ROTH DA, GOLD LI, HAN VKM et al: Immunolocalizations of transforming growth factor 131, in, and 133 and insulin-like growth factor I in premature fusion. Plast. Reconsm. Surg. (1997) 99:300–309.
   PubMed Web of Science ®Google Scholar
• ROTH DA, LONGAKER MT, MCCARTHY JG et al.: Studies in cranial suture biology: Part I. Increased immunoreactivity for TGF-I3 isoforms (31, 32, and 33) during rat cranial suture fusion. J. Bone Miner. Res. (1997) 12:311–321.
   Google Scholar
• WARREN SM, BRUNET LJ, HARLAND RIVI et al.: The BMP antagonist noggin regulates cranial suture fusion. Nature (2003) 422:625–629.
   PubMed Web of Science ®Google Scholar
• ••Report using in vivo gene therapy toprevent suture fusion, suggesting a role for noggin expression in syndromic craniosynostosis.
   Google Scholar
• CHONG SL, MITCHELL R, MOURSI AM et al.: Rescue of coronal suture fusion using transforming growth factor-beta 3 (Tgf-beta3) in rabbits with delayed-onset craniosynostosis. Anat. Rec. (2003) 274A(2):962–971.
   Google Scholar
• MOONEY MP, LOSKEN HW, MOURSI A et al.: Inhibition of postoperative resynostosis with anti-TGF-I32 antibody. Dent. Res. (2002c) 81 (Spec. Iss.):A–221.
   Google Scholar
• COHEN MM JR: Epidemiology of craniosynostosis. In: Craniosynostosis: Diagnosis, Evaluation, and Management. Cohen MM Jr, MacLean RE (Eds), Oxford University Press, New York (2000):112–118.
   Google Scholar
• ••Excellent review of the epidemiologyof craniosynostosis.
   Google Scholar
• JABS EW: Genetics etiologies of craniosynostosis. In: Understanding Craniofacial Anomalies: The Etiopathogenesis of Craniosynostoses and Facial Clefting. Mooney MP, Siegel MI (Eds), John W. Wiley and Sons, New York (2002):125–146.
   Google Scholar
• ••Excellent review of the aetiologyof craniosynostosis.
   Google Scholar
• PASSOS-BUENO MR, WILCOX WR, JABS EW et al.: Clinical spectrum of fibroblast growth factor receptor mutations. Hum. Mutat (1999) 14:115–125.
   PubMed Web of Science ®Google Scholar
• REARDON W, WINTER RIVI, RUTLAND P et al.: Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat. Genet. (1994) 8:98–103.
   PubMed Web of Science ®Google Scholar
• WILKIE AOM, MORRISS-KAY GM, JONES EY et al.: Functions of fibroblast growth factors and their receptors. Curr. Biol. (1995) 5:500–507.
   PubMed Web of Science ®Google Scholar
• PARK WJ, THEDA C, MAESTRI NE et al.: Analysis of phenotypic features and FGER2 mutations in Apert syndrome. Am. J. Hum. Genet. (1995) 57:321–328.
   PubMed Web of Science ®Google Scholar
• MUENKE M, GRIPP KW, MCDONALD-MCGINN DM et al: A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am. J. Hum. Genet. (1997) 60:555–564.
   PubMed Web of Science ®Google Scholar
• PAZNEKAS WA, CUNNINGHAM ML, HOWARD TD et al.: Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutations. Am. j Hum. Genet. (1998) 62:1370–1380.
   PubMed Web of Science ®Google Scholar
• JABS EW: A TWIST in the fate of human osteoblasts identifies signaling molecules involved in skull development. Clin. Invest. (2001) 107:1075–1077.
   Google Scholar
• MURRAY SS, GLACKIN CA, WINTERS KA et al.: Expression of helix-loop-helix regulatory genes during differentiation of mouse osteoblastic cells. J. Bone Miner. Res. (1992) 7:1131–1138.
   PubMed Web of Science ®Google Scholar
• JABS EW, MULLER U, LI X et al: A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell (1993) 75:443–450.
   PubMed Web of Science ®Google Scholar
• MA L, GOLDEN S, WU L et al.: The molecular basis of Boston-type craniosynostosis: the Pro148- His mutation in the N-terminal arm of the MSX2 homeodomain stabilizes DNA binding without altering nucleotide sequence preferences. Hum. Mol. Genet. (1996) 5:1915–1920.
   PubMed Web of Science ®Google Scholar
• HALL BK: The induction of neural crest-derived cartilage and bone by embryonic epithelia: an analysis of the mode of action of an epithelial-mesenchymal interaction. J. Embryo]. Exp. Morph. (1981) 64:305–320.
   PubMedGoogle Scholar
• HALL BK, MIYAKE T: The membranous skeleton: the role of cell condensations in vertebrate skeletogenesis. Anat. Embryo]. (1992) 186:107–124.
   PubMedGoogle Scholar
• HALL BK, MIYAKE T: Divide, accumulate, differentiate: cell condensation in skeletal development revisited. Int. J. Dev. Biol. (1995) 39:881–893.
   PubMed Web of Science ®Google Scholar
• HALL BK, MIYAKE T: All for one and onefor all: condensations and the initiation of skeletal development. Bioessays (2000) 22:138–147.
   PubMed Web of Science ®Google Scholar
• KOKICH VG: The biology of sutures. In: Craniosynostosis, Diagnosis, Evaluation and Management. Cohen MMJ (Ed.), Raven Press, New York (1986):81–103.
   Google Scholar
• JIANG X, ISEKI S, MAXSON RE et al.: Tissue origins and interactions in the mammalian skull vault. Dev. Biol. (2002) 241:106–116.
   PubMedGoogle Scholar
• OPPERMAN L, SWEENEY TM, REDMON J et al.: Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures. Dev. Dyn. (1993) 198:312–322.
   Google Scholar
• OPPERMAN LA, PERSING JA, SHEEN R et al.: In the absence of periosteum, transplanted fetal and neonatal rat coronal sutures resist osseous obliteration. J. Craniolac. Surg. (1994) 5:327–332.
   PubMedGoogle Scholar
• OPPERMAN LA, PASSARELLI R, MORGAN EP et al.: Cranial sutures require tissue interactions with dura mater to resist osseous obliteration M vitro. J. Bone Min. Res. (1995) 10:1978–1987.
   PubMed Web of Science ®Google Scholar
• ROTH DA, BRADLEY JP, LEVINE JP et al.: Studies in cranial suture biology: Part II. Role of the dura in cranial suture fusion. Plast. Reconstr. Surg. (1996) 97:693–699.
   PubMed Web of Science ®Google Scholar
• KIM HJ, RICE DP, KETTUNEN PJ et al.:FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development (1998) 125:1241–1251.
   PubMed Web of Science ®Google Scholar
• OPPERMAN LA, PASSARELLI R, NOLAN AA eta].: Dura mater secretes soluble heparin-binding factors required for cranial suture morphogenesis. In Vitro Cell. Dev. Biol. (1996) 32:627–632.
   Google Scholar
• LIU YH, KUNDU R, WU L et al: Premature suture closure and ectopic cranial bone in mice expressing Msx2 transgenes in the developing skull. Proc. Natl. Acad. Sci. USA (1995) 92:6137–6141.
   PubMed Web of Science ®Google Scholar
• OPPERMAN LA, NOLAN AA, OGLE RC: TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro [see comments]. Bone Min. Res (1997) 12:301–310.
   Google Scholar
• MEHRARA BJ, MACKOOL RJ, MCCARTHY JG et al: Immunolocalization of basic fibroblast growth factor and fibroblast growth factor receptor-1 and receptor-2 in rat cranial sutures. Plast. Reconstr. Surg. (1998) 102:1805–1817.
   PubMed Web of Science ®Google Scholar
• BRADLEY JP, HAN VK, ROTH DA et al.: Increased IGF-I and IGF-II mRNA and IGF-I peptide in fusing rat cranial sutures suggest evidence for a paracrine role of insulin-like growth factors in suture fusion. Plast. Reconstr. Surg. (1999) 104:129–138.
   PubMed Web of Science ®Google Scholar
• GRAVE B: Localization of TGF-Bs and perlecan in mouse skull development. Ann. Royal Australasian Coll Dent. Surg. (2000) 15:352–356.
   PubMedGoogle Scholar
• ADAB K, SAYNE JR, CARLSON DS et al: Tgf-131, Tgf- 32, Tgf- 33 and Msx2 expression is elevated during frontonasal suture morphogenesis and during active postnatal facial growth. Orthod. Craniofac. Res. (2002) 5:227–237.
   PubMedGoogle Scholar
• BARONI T, LILLI C, MARINUCCI L et al.: Crouzon's syndrome: differential in vitro secretion of bFGF, TGFbeta I isoforms and extracellular matrix macromolecules in patients with FGFR2 gene mutation. Cytokine (2002) 19:94–101.
   PubMed Web of Science ®Google Scholar
• HAJIHOSSEINI MK, HEARH JK: Expression patterns of fibroblast growth factors-18 and -20 in mouse embryos is suggestive of novel roles in calvarial and limb development. Mech. Dev. (2002) 113:79–83.
   PubMed Web of Science ®Google Scholar
• RICE DP, ABERG T, CHAN Y et al: Integration of FGF and TWIST in calvarial bone and suture development. Development (2000) 127:1845–1855.
   PubMed Web of Science ®Google Scholar
• MOST D, LEVINE JP, CHANG J et al: Studies in cranial suture biology: up-regulation of transforming growth factor-betal and basic fibroblast growth factor mRNA correlates with posterior frontal cranial suture fusion in the rat. Plast. Reconstr. Surg. (1998) 101:1431–1440.
   PubMed Web of Science ®Google Scholar
• RICE DP, KIM HJ, THESLEFF I: Apoptosis in murine calvarial bone and suture development. Eur: J. Oral Sci. (1999) 107:265–275.
   PubMed Web of Science ®Google Scholar
• AKITA S, HIRANO A, FUJII T: Identification of IGF-I in the calvarial suture of young rats: histochemical analysis of the cranial sagittal sutures in a hyperthyroid rat model. Plast. Reconstr. Surg. (1996) 97:1–12.
   PubMed Web of Science ®Google Scholar
• ISEKI S, WILKIE AO, MORRISS-KAY GM: Fgfrl and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault. Development (1999) 126:5611–5620.
   PubMed Web of Science ®Google Scholar
• ISEKI S, WILKIE AO, HEATH JK et al.: Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. Development (1997) 124:3375–3384.
   PubMed Web of Science ®Google Scholar
• JOHNSON D, ISEKI S, WILKIE AO et al.: Expression patterns of Twist and Fgfrl, -2 and -3 in the developing mouse coronal suture suggest a key role for twist in suture initiation and biogenesis. Mech. Dev. (2000) 91:341–345.
   PubMed Web of Science ®Google Scholar
• MEHRARA BJ, STEINBRECH DS, SAADEH PB et al.: Expression of high-affinity receptors for TGF-beta during rat cranial suture fusion. Ann. Plast. Surg. (1999) 42:502–508.
   PubMed Web of Science ®Google Scholar
• OPPERMAN LA, GALANIS V, WILLIAMS AR et al.: Transforming growth factor-beta3 (Tgf-I33) down-regulates Tgf-I3 receptor type I (TPr-I) during rescue of cranial sutures from osseous obliteration. Orthod. Craniofac. Res (2002) 5:5–16.
   PubMedGoogle Scholar
• OPPERMAN LA, MOURSI A, SAYNE JR et al.: Transforming growth factor-beta 3 (Tgf-33) in a collagen gel delays fusion of the rat posterior interfrontal suture in vivo. Anat. Rec. (2002) 267:120–130.
   PubMedGoogle Scholar
• SATOKATA I, MA L, OHSHIMA H et al: Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat. Genet. (2000) 24:391–395.
   PubMed Web of Science ®Google Scholar
• LIU YH, TANG Z, KUNDU RK et al: Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: a possible mechanism for MSX2-mediated craniosynostosis in humans. Dev. (1999) 205:260–274.
   Google Scholar
• KOMORI T, YAGI H, NOMURA S et al: Targeted disruption of Cbfal results in a complete lack of bone formation owing to maturational arrest of osteoblasts [see comments]. Cell (1997) 89:755–764.
   PubMed Web of Science ®Google Scholar
• OTTO F, THORNELL AP, CROMPTON T et al.: Cbfal, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development [see comments]. Cell (1997) 89:765–771.
   PubMed Web of Science ®Google Scholar
• ZHOU YX, XU X, CHEN L et al.: A Pro250Arg substitution in mouse Fgfrl causes increased expression of Cbfal and premature fusion of calvarial sutures. Hum. MM. Genet. (2000) 9:2001–2008.
   PubMed Web of Science ®Google Scholar
• ANDERSON J, BURNS HD, ENRIQUEZ-HARRIS P et al.: Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. Hum. Ma Genet (1998) 7:1475–1483.
   PubMed Web of Science ®Google Scholar
• MOURSI AM, WINNARD PL, WINNARD AV RUBENSTRUNK JM, MOONEY MP: Fibroblast growth factor 2 induces increased calvarial osteoblast proliferation and cranial suture fusion. Cleft Palate Craniofac. J. (2002) 39:487–496.
   PubMed Web of Science ®Google Scholar
• KIM HJ, LEE MH, PARK HS et al: Erk pathway and activator protein 1 play crucial roles in FGF2-stimulated premature cranial suture closure. Dev. Dpi. (2003) 227:335–346.
   PubMed Web of Science ®Google Scholar
• IGNELZI MA JR, WANG W, YOUNG AT et al.: Fibroblast growth factors lead to increased Msx2 expression and fusion in calvarial sutures: expression profiles of craniosynostosis-derived fibroblasts. Bone Miner. Res (2003) 18:751-759. Ha WARREN SM, GREENWALD JA, SPECTOR JA et al.: New developments in cranial suture research. Plast. Reconstr. Surg. (2001) 107:523–540.
   Google Scholar
• CARLTON MB, COLLEDGE WH, EVANS MJ: Crouzon-like craniofacial dysmorphology in the mouse is caused by an insertional mutation at the Fgf3/Fgf4 locus. Dev. Dpi. (1998) 212:242–249.
   PubMed Web of Science ®Google Scholar
• COFFIN JD, FLORKIEWICZ RZ, NEUMAN J et al.: Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol. Biol. Cell (1995) 6:1861–1873.
   PubMed Web of Science ®Google Scholar
• LOMRI A, LEMONNIERJ, HOTT M: Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome. I. Clin. Invest. (1998) 101:1310–1317.
   PubMed Web of Science ®Google Scholar
• LEMONNIER J, HAY E, DELANNOY P et al.: Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis. J. Bone Miner. Res. (2001) 16:832–845.
   PubMed Web of Science ®Google Scholar
• MORRISS-KAY GM, ISEKI S, JOHNSON D: Genetic control of the cell proliferation-differentiation balance in the developing skull vault: roles of fibroblast growth factor receptor signaling pathways. Novartis Found. Symp. (2001) 232:102–116.
   PubMedGoogle Scholar
• YOUSFI M, LASMOLES F, LOMRI A et al.: Increased bone formation and decreased osteocalcin expression induced by reduced Twist dosage in Saethre-Chotzen syndrome. [comment]. Clin. Invest. (2001) 107:1153–1161.
   PubMed Web of Science ®Google Scholar
• ESWARAKUMAR VP, MONSONEGO-ORNAN E et al: The Mc alternative of Fgfr2 is a positive regulator of bone formation. Development (2002) 129:3783–3793.
   PubMed Web of Science ®Google Scholar
• MARIE PJ, DEBIAIS F, HAY E. Regulation of human cranial osteoblast phenotype by EGE-2, EGER-2 and BMP-2 signaling. Histol Histopathol (2002) 17:877–885.
   Google Scholar
• HOLLVILLE N, QUILHAC A, BORTOUX M et al.: BMP signals regulate D1x5 during early avian skull development. Dev. Biol. (2003) 257:177–189.
   PubMed Web of Science ®Google Scholar
• MATHUSSEN IM, VAN LEEUWEN H, VERIVIEU-KEERS C, VAANDRAGER JM: FGF-4 or EGE-2 administration induces apoptosis, collagen type I expression, and mineralization in the developing coronal suture. Craniofac. Surg. (2001) 12:399–400.
   PubMed Web of Science ®Google Scholar
• MATHUSSEN IM, VAN LEEUWEN H, VERIVIEU-KEERS C: Simultaneous induction of apoptosis, collagen type I expression and mineralization in the developing coronal suture following FGF4 and EGE2 application.j Craniofac. Genet. Dev. Biol. (2000) 20:127–136.
   PubMedGoogle Scholar
• MATHY JA, LENTON K, NACAMULI RP et al.: EGE-2 stimulation affects calvarial osteoblast biology: quantitative analysis of nine genes important for cranial suture biology by real-time reverse transcription polymerase chain reaction. Plast. Reconstr. Surg. (2003) 112:528–539.
   PubMed Web of Science ®Google Scholar
• SPECTOR JA, GREENWALD JA, WARREN SM et al.: Dura mater biology: autocrine and paracrine effects of fibroblast growth factor 2. Plast. Reconstr. Surg. (2002) 109:645–654.
   PubMed Web of Science ®Google Scholar
• FRAGALE A, TARTAGLIA M, BEMARDINI S et al.: Decreased proliferation and altered differentiation in osteoblasts from genetically and clinically distinct craniosynostotic disorders. Am. J. Pathol (1999) 154:1465–1477.
   PubMed Web of Science ®Google Scholar
• LEMONNIER J, DELANNOY P, HOTT M, LOMRI A, MODROWSKI D, MARIE PJ. The Ser252Trp fibroblast growth factor receptor-2 (FGER-2) mutation induces PKC-independent downregulation of EGER-2 associated with premature calvaria osteoblast differentiation. Exp. Cell Res (2000) 256:158–167.
   PubMed Web of Science ®Google Scholar
• OPPERMAN LA, CHHABRA A, NOLEN AA, BAO Y, OGLE RC: Increased cell proliferation and altered collagen production precede rat cranial suture fusion in vitro. Ma Biol. Cell(1997) 8:329a.
   Google Scholar
• OPPERMAN LA, ADAB K, GAKUNGA PT: TGE-B2 and TGE-B3 regulate fetal rat cranial suture morphogenesis by regulating rates of cell proliferation and apoptosis. Dev. Dpi. (2000) 219:237–247.
   PubMed Web of Science ®Google Scholar
• OPPERMAN LA, CHHABRA A, CHO RW, OGLE RC: Cranial suture obliteration is induced by removal of transforming growth factor (TGF)-beta 3 activity and prevented by removal of TGF-beta 2 activity from fetal rat calvaria M vitro. .1. Craniofac. Genet. Dev. Biol. (1999) 19:164–173.
   PubMedGoogle Scholar
• OPPERMAN LA, CHHABRA A, NOLEN AA, BAO Y, OGLE RC: Dura mater maintains rat cranial sutures in vitro by regulating suture cell proliferation and collagen production. J. Craniofac. Genet. Dev. Biol. (1998) 18:150–158.
   PubMedGoogle Scholar
• CHEIFEZ S, HERNANDEZ H, LAIHO M, TEN DUKE P, IWATA KK, MASSAGUE J: Distinct transforming growth factor-beta (TGF-beta) receptor subsets as determinants of cellular responsiveness to three TGF-beta isoforms. Biol. Chem (1990) 265:20533–20538.
   Web of Science ®Google Scholar
• LEWANDOSKI M, MEYERS EN, MARTIN GR: Analysis of Egi8 gene function in vertebrate development. Cold Spring Harbor SyMp. Quant. Biol. (1997) 62:159–168.
   PubMedGoogle Scholar
• MARTINEZ S, CROSSLEY PH, COBOS I, RUBENSTEIN JL, MARTIN GR: FGF8 induces formation of an ectopic isthmic organizer and isthmocerebellar development via a repressive effect on Otx2 expression. Development (1999) 126:1189–1200.
   PubMed Web of Science ®Google Scholar
• MEYERS EN, MARTIN GR: Differences in left-right axis pathways in mouse and chick: functions of FGF8 and SHH. Science (1999) 285:403–406.
   PubMedGoogle Scholar
• TRUMPP A, DEPEW MJ, RUBENSTEIN JL, BISHOP JM, MARTIN GR: Cre-mediated gene inactivation demonstrates that FGF8 is required for cell survival and patterning of the first branchial arch. Genes Dev. (1999) 13:3136–3148.
   PubMed Web of Science ®Google Scholar
• ABERG T, WOZNEY J, THESLEFF I: Expression patterns of bone morphogenetic proteins (Bmps) in the developing mouse tooth suggest roles in morphogenesis and cell differentiation. Dev. Dpi. (1997) 210:383–396.
   PubMed Web of Science ®Google Scholar
• JERNVALL J, ABERG T, KETTUNEN P, KERNEN S, THESLEFF I: The life history of an embryonic signaling center: BMP-4 induces p21 and is associated with apoptosis in the mouse tooth enamel knot. Development (1998) 125:161–169.
   PubMed Web of Science ®Google Scholar
• THESLEFF I, ABERG T: Molecular regulation of tooth development. Bone (1999) 25:123–125.
   Google Scholar
• VOGEL A, ROBERTS-CLARKE D, NIS WANDER L: Effect of FGF on gene expression in chick limb bud cells in vivo and M vitro. Dev. Biol (1995) 171:507–520.
   PubMed Web of Science ®Google Scholar
• MACIAS D, GANAN Y, RODRIGUEZ-LEON J, MERINO R, HURLE JM: Regulation by members of the transforming growth factor beta superfamily of the digital and interdigital fates of the autopodial limb mesoderm. Cell Tiss. Res. (1999) 296:95–102.
   PubMed Web of Science ®Google Scholar
• MARTIN GR: The roles of FGFs in the early development of vertebrate limbs. Genes Dev. (1998) 12:1571–1586.
   PubMed Web of Science ®Google Scholar
• SUN X, LEWANDOSKI M, MEYERS EN, LIU YH, MAXSON RE JR, MARTIN GR: Conditional inactivation of Fgf4 reveals complexity of signalling during limb bud development. Nat. Genet. (2000) 25:83–86.
   PubMed Web of Science ®Google Scholar
• TOWLER DA, RUTLEDGE SJ, RODAN GA: Msx-2/Hox 8.1: a transcriptional regulator of the rat osteocalcin promoter. Ma. Endocrinol (1994) 8:1484–1493.
   Google Scholar
• DODIG M, KRONENBERG MS, BEDALOV A et al.: Identification of a TAAT-containing motif required for high level expression of the COL1A1 promoter in differentiated osteoblasts of transgenic mice. J. Biol. Chem. (1996) 271:16422–16429.
   PubMed Web of Science ®Google Scholar
• EL GHOUZZI V, LEGEAI-MALLET L, ARESTA S et al.: Saethre-Chotzen mutations cause TWIST protein degradation or impaired nuclear location. Hum. Ma Genet (2000) 9:813–819.
   PubMed Web of Science ®Google Scholar
• EL GHOUZZI V, LEGEAI-MALLET L, BENOIST-LASSELIN C et al.: Mutations in the basic domain and the loop-helix II junction of TWIST abolish DNA binding in Saethre-Chotzen syndrome. FEBS Lett (2001) 492:112–118.
   PubMed Web of Science ®Google Scholar
• YOUSFI M, LASMOLES F, KERN B, MARIE PJ: TWIST inactivation reduces CBFA1/RUNX2 expression and DNA binding to the osteocalcin promoter in osteoblasts. Biochem. Biophys. Res. Commun (2002) 297:641–644.
   PubMed Web of Science ®Google Scholar
• YOUSFI M, LASMOLES F, EL GHOUZZI V, MARIE PJ: Twist haploinsufficiency in Saethre-Chotzen syndrome induces calvarial osteoblast apoptosis due to increased TNFalpha expression and caspase-2 activation. Hum. Ma Genet (2002) 11:359–369.
   PubMed Web of Science ®Google Scholar
• RICE DP, RICE R, THESLEFF I: Molecular mechanisms in calvarial bone and suture development, and their relation to craniosynostosis. Lim J Orthod (2003) 25:139–148.
   Google Scholar
• DUCY P: Cbfal: a molecular switch in osteoblast biology. Dev. Dyn. (2000) 219:461–471.
   PubMed Web of Science ®Google Scholar
• MUNDLOS S, OTTOF, MUNDLOS C et al.: Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia [see comments]. Cell (1997) 89:773–779.
   PubMed Web of Science ®Google Scholar
• ZHOU G, CHEN Y, ZHOU L et al.: CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia. Hum. Mol. Genet (1999) 8:2311–2316.
   PubMed Web of Science ®Google Scholar
• ZHANG YVV, YASUI N, ITO K et al.: A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc. Natl. Acad. Sci. USA (2000) 97:10549–10554.
   PubMed Web of Science ®Google Scholar
• WANG EA, ISRAEL DI, KELLY S, LUXENBERG DP: Bone morphogenetic protein-2 causes commitment and differentiation in c3h10t1/2 and 3t3 cells. Growth Factors (1993) 9:57–71.
   PubMed Web of Science ®Google Scholar
• BABENSEE JE, MCINTIRE LVMIKOS AG: Growth factor delivery for tissue engineering. Pharm. Res. (2000) 17:497–504.
   PubMed Web of Science ®Google Scholar
• HAN S, MAHATO RI, SUNG YK, KIM SW: Development of biomaterials for gene therapy. MM. Ther (2000) 2:302–317.
   PubMed Web of Science ®Google Scholar
• LIEBERMAN JR, DALUISKI A, EINHORN T, APUZAS JE: The role of growth factors in the repair of bone. Biology and clinical applications the orthopaedic genome: what does the future hold and are we ready? Bone Joint Surg. (2002) 84-A:1032–1044.
   Google Scholar
• SALTZMAN W, MOLBRICHT WL: Building drug delivery into tissue engineering. Nat. Rev Drug Discov (2002) 1:177–186.
   PubMed Web of Science ®Google Scholar
• •Excellent review of the state of the art techniques in controlled drug delivery and their potential clinical applications.
   Google Scholar
• SCHILEPHAKE H: Bone growth factors in maxillofacial skeletal reconstruction. Int. J Oral Maxillofac. Surg. (2002) 31:469–484.
   PubMed Web of Science ®Google Scholar
• •Good review of available cytokines and clinical applications in the head and neck.
   Google Scholar
• NABEL EG, YANG ZY, FOX BA et al.: Direct gene transfer: Basic studies and human therapies. Proc. Natl Acad. ScL USA (1993) 90:11307–11311.
   PubMed Web of Science ®Google Scholar
• FRIESS W: Collagen-biomaterial for drug delivery. Eur. J Pharm. Biopharm (1998) 45:113–136.
   PubMed Web of Science ®Google Scholar
• LEE CH, SINGLA A, LEE Y: Biomedical applications of collagen. Int. J Pharmaceut. (2001) 221:1–22.
   PubMed Web of Science ®Google Scholar
• •Comprehensive review of the many clinical applications for collagen, including drug delivery.
   Google Scholar
• ULUDAG H, D& AUGUSTA D, PALMER R et al.: Characterization of rhbmp-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. Biomed. Mater. Res. (1999) 46:193–202.
   Google Scholar
• BOYNE PJ, MARX RE, NEVINS M et al: A feasibility study evaluating rhbmp-2/ absorbable collagen sponge for maxillary sinus floor augmentation. Int. J Periodont Restor. Dent. (1997) 17:11–25.
   PubMed Web of Science ®Google Scholar
• YAMAMOTO M, TABATA Y, HONG L et al.: Bone regeneration by transforming growth factor betal released from a biodegradable hydrogel. Control. Rel. (2000) 64:133–142.
   PubMed Web of Science ®Google Scholar
• DELUSTRO F, CONDELL RA, NGUYEN MA et al.: A comparative study of the biologic and immunologic response to medical devices derived from dermal collagen. J Biomed. Mater. Res. (1986) 20:109–120.
   PubMed Web of Science ®Google Scholar
• ELLINGSWORTH LR, DELUSTRO F, BRENNAN JE et al.: The human immune response to reconstituted bovine collagen. J Immunol (1986) 136:877–882.
   PubMed Web of Science ®Google Scholar
• PACHENCE JM: Collagen-based devices for soft tissue repair. J Biomed. Mater. Res. (1996) 33:35–40.
   PubMed Web of Science ®Google Scholar
• ROSENBLATT J, RHEE W, WALLACE D: The effect of collagen fiber size distribution on the release rate of proteins from collagen matrices by diffusion. Control. Rel. (1989) 9:195–203.
   Web of Science ®Google Scholar
• BENTZ H, SCHROEDER JA, ESTRIDGE TD: Improved local delivery of tgf-beta2 by binding to injectable fibrillar collagen via difunctional polyethylene glycol. .1 Biomed. Mater. Res (1998) 39:539–548.
   PubMed Web of Science ®Google Scholar
• SCHROEDER-TEFFT JA, BENTZ H, ESTRIDGE, TD: Collagen and heparin matrices for growth factor delivery. J. Control. Rel. (1997) 49:291–298.
   Web of Science ®Google Scholar
• MOURSI AM, WINNARD PL, WINNARD AV, MOONEY MP: Tgf beta-2 in a collagen gel induces rat cranial suture fusion. Dent. Res (2000) 79:415.
   Web of Science ®Google Scholar
• MOURSI AM, WINNARD PL, FRYER D, MOONEY MP: Delivery of transforming growth factor-beta2-perturbing antibody in a collagen vehicle inhibits cranial suture fusion in calvarial organ culture. Cleft Palate Craniofac. J. (2003) 40:225–232.
   PubMed Web of Science ®Google Scholar
• MORGAN DM, MOURSI AM WINNARD PL: Effects of tgf beta-3 on rat osteoblasts and cranial sutures. J. Dent. Res. (2004) (In Press).
   Google Scholar
• BODEN SD, ZDEBLICK TA, SAND HU et al.: The use of rhbmp-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine (2000) 25:376–381.
   Google Scholar
• FRIEDLAENDER GE: Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. [comment]. J Bone Joint Surg. (2001) 83-A\(Suppl. 1):5160–5161.
   Google Scholar
• HOWELL TH, FIORELLINI JP, PAQUETTE DW et al: A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J Periodon. (1997) 68:1186–1193.
   PubMed Web of Science ®Google Scholar
• BOWEN-POPE DF, MALPASS TW, FOSTER R et al.: Platelet-derived growth factor in vivo: levels, activity, and rate of clearance. Blood (1984) 64:458–469.
   PubMed Web of Science ®Google Scholar
• EDELMAN ER, NUGENT MA, KARNOVSKY MJ: Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition. Proc. Natl Acad. Sci. USA (1993) 90:1513–1517.
   PubMed Web of Science ®Google Scholar
• BONADIO J, CUNNINGHAM ML: Genetic approaches to craniofacial tissue repair. Ann. NY Acad. Sci. (2002) 961:48–57.
   PubMed Web of Science ®Google Scholar
• TEPPER OM, MEHRARA BJ: Gene therapy in plastic surgery. Plast. Reconsm Stow. (2002) 109:716–734.
   PubMed Web of Science ®Google Scholar
• WARREN SM, FONG KD, CHEN CM et al.: Tools and techniques for craniofacial tissue engineering. Tics. Eng. (2003) 9:187–200.
   Google Scholar
• •Review of the various methods available for gene and cell transfer in craniofacial tissue engineering.
   Google Scholar
• O'CONNELL BC, LILLIBRIDGE CD, AMBUDKAR I et al.: Somatic gene transfer to salivary glands. Ann. NY Acad. Sci. (1998) 842:171–180.
   PubMedGoogle Scholar
• ALDEN TD, BERES EJ, LAURENT JS et al.: The use of bone morphogenetic protein gene therapy in craniofacial bone repair. J. Craniofac. Surg. (2000) 11:24–30.
   PubMed Web of Science ®Google Scholar
• LINDSEY WH: Osseous tissue engineering with gene therapy for facial bone reconstruction. Laryngoscope (2001) 111:1128–1136.
   PubMed Web of Science ®Google Scholar
• MEHRARA BJ, SPECTOR JA, GREENWALD JA et al.: Adenovirus-mediated transmission of a dominant negative transforming growth factor-beta receptor inhibits in vitro mouse cranial suture fusion. Plast Remus& Surg (2002) 110:506–514.
   PubMed Web of Science ®Google Scholar
• BANERJEE RR, LAZAR MA: Dimerization of resistin and resistin- like molecules is determined by a single cysteine. Biomat. Appl. (2001) 16:3–21.
   PubMed Web of Science ®Google Scholar
• GIANNOBILE WV: Periodontal tissue engineering by growth factors. Bone (1996) 19:23S–37S.
   Google Scholar
• BONADIO J, SMILEY E, PATIL S et al.: Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat. Med. (1999) 5:753–759.
   PubMed Web of Science ®Google Scholar
• •Report on the use of non-viral vectors to deliver plasmid DNA in a polymer matrix for prolonged gene expression and in vivo bone formation.
   Google Scholar
• PREMERAJ S, PARKER-BARNES J, MOURSI AM et al.: Collagen gel delivery of Tgf beta-3 gene in calvarial osteoblasts. .1. Dent. Res. (2004) (In Press).
   Google Scholar
• BREITBART AS, GRANDE DA, MASON JM et al.: Gene-enhanced tissue engineering: applications for bone healing using cultured periosteal cells transduced retrovirally with the bmp-7 gene. Ann. Plast. Surg. (1999) 42:488–495.
   PubMed Web of Science ®Google Scholar
• COHEN MM JR: Sutural1T pathology: Craniosynostosis: Diagnosis, Evaluation, and Management. Cohen MM Jr, MacLean RE (Eds). Oxford University Press, New York (2000):95–99.
   Google Scholar
• MOONEY MP, SIEGEL MI, OPPERMAN LA: Animal models of craniosynostosis: experimental, congenital, and transgenic. In: Understanding Craniofacial Anomalies: The Etiopathogenesis of Craniosynostosis and Facial Clefting. Mooney MP, Siegel MI (Eds). John W. Wiley and Sons, New York (2002):251–272.
   Google Scholar
• •Comprehensive and recent review of available animal models of craniosynsotosis.
   Google Scholar
• VANNIER MW: Radiologic evaluation of craniosynostosis. In: Craniosynostosis: Diagnosis, Evaluation, and Management Cohen MM Jr, MacLean RE (Eds), Oxford University Press, New York (2000):147–157.
   Google Scholar
• STELNICKI EJ, MOONEY MP, LOSKEN HW et al.: Ultrasonic prenatal diagnosis of coronal suture synostosis. .1 Craniofac. Surg. (1997) 8:252–258.
   Google Scholar
• MILLER C, LOSKEN HW, TOWBIN R et al.: Ultrasound diagnosis of craniosynostosis. Cleft Palate Craniofac. .1. (2002) 39:73-80.
   Google Scholar